.

A two-year study of the new cyclosporine formulation consupren in De Novo Renal transplant patients

LAUR Repository

A two-year study of the new cyclosporine formulation consupren in De Novo Renal transplant patients

Karam, A.; Mokhbat, J.; Kilany, H.; Stephan, A. G.; Barbari, A.; Masri, M.; Kamel, G.; Khoury, W. Barakat
URI: http://hdl.handle.net/10725/5284
URL: http://ku7rj9xt8c.scholar.serialssolutions.com/?sid=google&auinit=AG&aulast=Stephan&atitle=A+two-year+study+of+the+new+cyclosporine+formulation+Consupren+in+de+novo+renal+transplant+patients&id=doi:10.1016/S0041-1345(98)01136-1&title=Transplantation+proceedings&volume=30&issue=7&date=1998&spage=3563&issn=0041-1345
DOI: http://dx.doi.org/10.1016/S0041-1345(98)01136-1
Date: 2017-02-27
Terms of Use: This item is made available under the terms and conditions applicable to " Article ", as set forth at: http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php

Abstract:

WE have shown in a previous study that converting renal transplant recipients from regular Sandimmun (SIM) to the new cyclosporine A (CyA) formulation Consupren (CON) could be achieved safely with preservation of a good graft function, no added renal or extrarenal toxicity, and with significant cost benefits. The present study extends the use of CON as a primary immunosuppressant drug utilized de novo in the immediate posttransplant period

Citation:

Stephan, A. G., Barbari, A., Masri, M., Kamel, G., Khoury, W. B., Karam, A., ... & Kilany, H. (1998, November). A two-year study of the new cyclosporine formulation Consupren in de novo renal transplant patients. In Transplantation proceedings 30(7), 3563-3564

Access Status:

N/A

Show full item record

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search LAUR


Advanced Search

Browse

My Account